INVO Bioscience Announces First Shipments of INVOcell In... ( BEVERLY Mass. Dec. 21 2010 /- INVO Bi...)

INVO Bioscience Announces First Shipments of INVOcell Into Bolivia

Date:12/21/2010

BEVERLY, Mass., Dec. 21, 2010 /PRNewswire/ -- INVO Bioscience, Inc. (OTC Bulletin Board: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced the initial shipments of the INVOcell device into Bolivia. The initial order of INVOcell devices was purchased by The National Center for Fertility and Sterility (CENALFES). Under the direction of clinic director Dr. Joaquin Lopez Arana and embryologist Dr. Patricia Frias, CENALFES is the largest infertility treatment center in Bolivia, having assisted more than 4,000 infertility patients over the past 20 years resulting in more than 1,500 births. Bolivia represents the fourth country in South America where fertility clinics have ordered INVOcell.

Bolivia has approximately 5 fertility centers licensed to perform assisted reproductive procedures. According to the Bolivian Health Ministry there are more than 1.8 million infertile couples in Bolivia, however less than 1,000 couples per year engage in assisted reproductive procedures, largely due to costs. Clinical results have demonstrated outstanding effectiveness of the INVOcell process without many of the inherent expenses associated with traditional in-vitro fertilization (IVF) procedures.

Kathleen Karloff, chief executive officer for INVO Bioscience, commented, "The company continues to execute on its stated goal of introducing the INVOcell device and process to many of the key opinion leaders throughout the world that will influence expanded acceptance and use of our products. CENALFES is one the largest providers of infertility treatments in Bolivia, which we expect to become a strong reference to the exceptional capabilities of INVOcell. We look forward to continue working with the many physicians at CENALFES and elsewhere in Bolivia to offer the many suffering infertile patients a cost
'/>"/>

SOURCE INVO Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Ambit Biosciences Initiates Two Phase I Clinical Trials
2. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
3. Cell Biosciences Announces US Patent Issuance
4. Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices
5. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
6. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
9. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
10. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
11. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010

Post Your Comments:

(Date:5/24/2013)... 24, 2013 Solta Medical, Inc. (NASDAQ: ... today reported Dr. Edward W. Knowlton ... Directors effective immediately. Dr. Knowlton is the founder of Thermage, ... a director since 1996. "On behalf of the ... I would like to thank Ed for his tireless dedication ...

(Date:5/24/2013)... 2013 An international roster of experts on malignant ... Santa Monica, Calif. , to discuss ... MPM, a rare form of cancer that results from ... lining of the chest. Hosted by UCLA ... 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant ...

(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and ... MicroCap Conference, which is being held May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2

[0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

... Minn., Sept. 25 CSL Plasma , one of ... from the Duluth area today as part of a statewide ... to Randy Furby, Senior Vice President and General Manager of ... raise awareness of rare genetic diseases treated with plasma-derived therapies ...

... Hologic, Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and surgical ... announced that the Radiological Devices Panel (Panel) of the ... that Hologic,s Pre-Market Approval (PMA) demonstrated both the effectiveness ...

Cached Medicine Technology:Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases 2 Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 2 Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 3 Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 4

Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel

(Date:5/24/2013)... According to a May 15, 2013 Time ... to Spikes in Plastic Surgery Requests,” a number ... of facial plastic surgery and cosmetic improvements among ... keenly aware of the need to look good online and ... and even Skype's video chat feature (Go to goo.gl/WO0PR). , ...

(Date:5/24/2013)... 24, 2013 The Dictation Source recently ... of clients. As a result of its National marketing ... in 20 states around the nation. , Since 1991, ... services to the healthcare industry . Dictation Source is ... their years of clinical work experience to provide the ...

(Date:5/24/2013)... BEACH, CA (PRWEB) May 24, 2013 ... health care education community, proudly participated in festivities surrounding ... April 19-21. The event provided the perfect backdrop to ... facilities at 236 E. 3rd Street, housed in an ... Arts Building. , ACC was an active exhibitor throughout ...

(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... Mobility® is a leading nationwide sales, installation ... for both consumer and commercial applications. The company’s ... platform lifts, vehicle lifts for mobility devices, pool ... others. 101 Mobility operates over 30 locations, primarily ...

(Date:5/24/2013)... The number of U.S. patients admitted to hospitals, ... emergency room has increased by nearly 50 percent, ... by researchers at the George Washington University School ... D.C., found that patients wait five hours in ... to the ICU. The researchers said improved coordination ...

Breaking Medicine News(10 mins):Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2 Health News:The Dictation Source Signs Two National Hospital Chains 2 Health News:The Dictation Source Signs Two National Hospital Chains 3 Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2 Health News:Cortec Closes Equity Transaction with 101 Mobility 2 Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2

[0] Facebook and Google – Is Social Media Driving Demand for Plastic Surgery?[0] The Dictation Source Signs Two National Hospital Chains [0] American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach [0] Cortec Closes Equity Transaction with 101 Mobility [0] Sharp Rise in ICU Admissions From U.S. Emergency Rooms

... Boston Scientific Corporation (NYSE: BSX ) today announced financial results ... for net sales and earnings per share (EPS) for the second quarter ... growth rates are constant currency): , , ... EPS of $0.19, both in line with guidance (GAAP loss per share ...

... should start with "evidence-based reimbursement", structuring physician payment ... which would improve quality and reduce the cost ... cardiologists and published in Circulation: Cardiovascular Quality ... example, some 500,000 U.S. patients suffering from mild ...

... San Diego was named a 2009 Clean Air Circle Honoree ... their annual Evening in the Sky Gala. Waste Management ... clean and ongoing efforts to protect the environment and promote ... working to promote clean air throughout San Diego, especially as ...

... needed economic boost to primary care services for Floridians ... Speaker Nancy Pelosi joined Rep. Debbie Wasserman Schultz today ... discuss the positive impact of the American Recovery and ... $10 million in federal stimulus money to fund eight ...

... glucose-based beverages may not have same impact, study finds ... drinks and other beverages can have a negative effect ... to handle fats, increasing the risk of heart attack ... glucose-sweetened beverages don,t have that kind of impact, the ...

... limits of procedure, study suggests , , MONDAY, April 20 ... removal of certain head and neck cancers, U.S. researchers ... cavity, throat or larynx tumors. Of those patients, 29 ... cancerous tissue. Negative margins (when no cancer cells are ...

Boston Scientific Announces Results For First Quarter Ended March 31, 2009 Health-care reform should start with paying evidence-based financial incentives to doctors Waste Management Honored by American Lung Association for Environmental Achievements Speaker Pelosi Visits Florida Health Center Fructose-Sweetened Drinks Up Metabolic Syndrome Risk Robotic Surgery Practical for Some Head, Neck Tumors

This revolutionary system combines the CSZ Head Wrap and Patient Vest for a non-invasive whole body hypothermia system. This method of cooling the patient allows for early treatment that is fast, cos...

The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....

The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....

Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...

Medicine Products:

Whole Body Hypothermia System COCOON Reusable Multi Purpose Bair Hugger® Model 111 - Preoperative/Outpatient Care Blanket COCOON Disposable Full Torso